179 related articles for article (PubMed ID: 25808918)
1. United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.
Gish RG; Wong RJ; Honerkamp-Smith G; Xu R; Osorio RW
Clin Transplant; 2015 Jun; 29(6):513-22. PubMed ID: 25808918
[TBL] [Abstract][Full Text] [Related]
2. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.
Braun HJ; Perito ER; Dodge JL; Rhee S; Roberts JP
Am J Transplant; 2016 Nov; 16(11):3181-3191. PubMed ID: 27214757
[TBL] [Abstract][Full Text] [Related]
3. Center variation in the use of nonstandardized model for end-stage liver disease exception points.
Goldberg DS; Makar G; Bittermann T; French B
Liver Transpl; 2013 Dec; 19(12):1330-42. PubMed ID: 24039090
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.
Swenson SM; Roberts JP; Rhee S; Perito ER
Am J Transplant; 2019 Dec; 19(12):3308-3318. PubMed ID: 31370108
[TBL] [Abstract][Full Text] [Related]
5. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
Lauferman L; Dip M; Halac E; Cervio G; Aredes D; Capparelli M; Reijenstein H; Minetto J; Rojas L; Goñi J; Jacobo Dillon A; Martinitto R; Imventarza O
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplantation in France.
Durand F; Antoine C; Soubrane O
Liver Transpl; 2019 May; 25(5):763-770. PubMed ID: 30697904
[TBL] [Abstract][Full Text] [Related]
7. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
[TBL] [Abstract][Full Text] [Related]
8. The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
Ahn DJ; Zeng S; Pelzer KM; Barth RN; Gallo A; Parker WF
Transplantation; 2023 Oct; 107(10):e247-e256. PubMed ID: 37408100
[TBL] [Abstract][Full Text] [Related]
9. MELD Exceptions and Rates of Waiting List Outcomes.
Massie AB; Caffo B; Gentry SE; Hall EC; Axelrod DA; Lentine KL; Schnitzler MA; Gheorghian A; Salvalaggio PR; Segev DL
Am J Transplant; 2011 Nov; 11(11):2362-71. PubMed ID: 21920019
[TBL] [Abstract][Full Text] [Related]
10. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
Maduka RC; Abt PL; Goldberg DS
Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
[TBL] [Abstract][Full Text] [Related]
11. Quantifying Sex-Based Disparities in Liver Allocation.
Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
[TBL] [Abstract][Full Text] [Related]
12. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
Mitchell E; Loomes KM; Squires RH; Goldberg D
Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
[TBL] [Abstract][Full Text] [Related]
13. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.
Chang CH; Bryce CL; Shneider BL; Yabes JG; Ren Y; Zenarosa GL; Tomko H; Donnell DM; Squires RH; Roberts MS
JAMA Pediatr; 2018 Nov; 172(11):1070-1077. PubMed ID: 30242345
[TBL] [Abstract][Full Text] [Related]
16. State-Based Liver Distribution: Broad Sharing With Less Harm to Vulnerable and Underserved Communities Compared With Concentric Circles.
Lynch RJ; Ye F; Sheng Q; Zhao Z; Karp SJ
Liver Transpl; 2019 Apr; 25(4):588-597. PubMed ID: 30873761
[TBL] [Abstract][Full Text] [Related]
17. Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
Mogul DB; Perito ER; Wood N; Mazariegos GV; VanDerwerken D; Ibrahim SH; Mohammad S; Valentino PL; Gentry S; Hsu E
Transplantation; 2020 Aug; 104(8):1627-1632. PubMed ID: 32732840
[TBL] [Abstract][Full Text] [Related]
18. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.
Croome KP; Lee DD; Burns JM; Keaveny AP; Taner CB
Liver Transpl; 2018 Apr; 24(4):488-496. PubMed ID: 29365357
[TBL] [Abstract][Full Text] [Related]
19. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
